drugset / Trial / NCT04454307
Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The rationale of the use of tramadol for COVID-19 patients is attributed to its anti-inflammatory, hypocagulatory, antioxidant, cardio-protective, analgesic, antitussive, bactericidal and antidepressant effect.
Timeline
- Start
- 2020-07
- Primary completion
- 2020-08
- Completion
- 2020-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tramadol | Other / unclassified | 100 mg | — |